Evidence map›Paper›PMID 29449546›Full record

ArticleNature communications2018

A community approach to mortality prediction in sepsis via gene expression analysis.

Timothy E Sweeney, Thanneer M Perumal, Ricardo Henao, Marshall Nichols, Judith A Howrylak, Augustine M Choi, Jesús F Bermejo-Martin, Raquel Almansa, Eduardo Tamayo, Emma E Davenport and 16 more

3 registry-linked trialsAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 148 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
148citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03606382 completednot on this map

Collection of Clinical Specimens From Volunteers for Assay Development

TypeobservationalSponsorInflammatixRan2018 to 2019Enrolled6ConditionsAcute Respiratory InfectionArmsHostDx Fever Test, HostDx Sepsis Test
NCT04094818 completednot on this mapstarted 2020, after this paper: background citation

TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis

TypeobservationalSponsorInflammatixRan2020 to 2024Enrolled1,441ConditionsRespiratory Tract Infections, Urinary Tract Infections, Intra-Abdominal Infections, Skin and Soft Tissue InfectionArmsTriVerity
NCT05639504 withdrawnnot on this mapstarted 2022, after this paper: background citation

Sepsis Prognosis and Diagnosis in the Emergency Department Using a Host Response Classifier (SPEED) UK - a Multi-Centre Observational Study

TypeobservationalSponsorInflammatixRan2022 to 2023Enrolled0ConditionsRespiratory Tract Infections, Urinary Tract Infections, Intra-Abdominal Infections, Skin and Soft Tissue InfectionArmsIMX-BVN-4 and IMX-SEV-4
3 · Its place in the literature

Who cites it

148 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Guideline
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Observational
  8. Article
  9. Observational
  10. Inflammatory Stewardship-A Perspective for Active Management of Acute Inflammation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

88 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Timothy E SweeneyStanford Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, 94305, USA.ORCID http://orcid.org/0000-0002-3596-1093
Thanneer M PerumalSage Bionetworks, Seattle, WA, 98109, USA.ORCID http://orcid.org/0000-0003-1168-8982
Ricardo HenaoCenter for Applied Genomics and Precision Medicine, Department of Medicine, Duke University, Durham, NC, 27708, USA.ORCID http://orcid.org/0000-0003-4980-845X
Marshall NicholsCenter for Applied Genomics and Precision Medicine, Department of Medicine, Duke University, Durham, NC, 27708, USA.
Judith A HowrylakDivision of Pulmonary and Critical Care Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA, 17033, USA.
Augustine M ChoiDepartment of Medicine, Cornell Medical Center, New York, NY, 10065, USA.
Jesús F Bermejo-MartinHospital Clínico Universitario de Valladolid/IECSCYL, Valladolid, 47005, Spain.
Raquel AlmansaHospital Clínico Universitario de Valladolid/IECSCYL, Valladolid, 47005, Spain.
Eduardo TamayoHospital Clínico Universitario de Valladolid/IECSCYL, Valladolid, 47005, Spain.
Emma E DavenportDepartment of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.ORCID http://orcid.org/0000-0002-8768-346X
Katie L BurnhamWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
Charles J HindsWilliam Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University, London, EC1M 6BQ, UK.ORCID http://orcid.org/0000-0001-5094-8324
Julian C KnightWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
Christopher W WoodsCenter for Applied Genomics and Precision Medicine, Department of Medicine, Duke University, Durham, NC, 27708, USA.
Stephen F KingsmoreRady Children's Institute for Genomic Medicine, San Diego, CA, 92123, USA.
Geoffrey S GinsburgCenter for Applied Genomics and Precision Medicine, Department of Medicine, Duke University, Durham, NC, 27708, USA.
Hector R WongDivision of Critical Care Medicine, Cincinnati Children's Hospital Medical Center and Cincinnati Children's Research Foundation, Cincinnati, OH, 45223, USA.
Grant P ParnellCentre for Immunology and Allergy Research, Westmead Institute for Medical Research, Westmead, NSW, 2145, Australia.
Benjamin TangCentre for Immunology and Allergy Research, Westmead Institute for Medical Research, Westmead, NSW, 2145, Australia.
Lyle L MoldawerDepartment of Surgery, University of Florida College of Medicine, Gainesville, FL, 32610, USA.
Frederick E MooreDepartment of Surgery, University of Florida College of Medicine, Gainesville, FL, 32610, USA.
Larsson OmbergSage Bionetworks, Seattle, WA, 98109, USA.
Purvesh KhatriStanford Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, 94305, USA.ORCID http://orcid.org/0000-0002-4143-4708
Ephraim L TsalikCenter for Applied Genomics and Precision Medicine, Department of Medicine, Duke University, Durham, NC, 27708, USA.ORCID http://orcid.org/0000-0002-6417-2042
Lara M MangraviteSage Bionetworks, Seattle, WA, 98109, USA.ORCID http://orcid.org/0000-0001-7841-3612
Raymond J LangleyDepartment of Pharmacology, University of South Alabama, Mobile, AL, 36688, USA. rlangley@southalabama.edu.ORCID http://orcid.org/0000-0001-8849-9325

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
ZUNI HEALTH INITIATIVE-PILOT STUDYP20RR016480 · NCRR · NEW MEXICO STATE UNIVERSITY LAS CRUCES · PI GRIFFITH, JEFFREY K · 2001 to 2011
$33.7M
UAB Center for Clinical and Translational Science (CCTS)UL1TR001417 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2015 to 2018
$31.4M
Translational Incubator CoreU19AI109662 · NIAID · STANFORD UNIVERSITY · PI GLENN, JEFFREY S · 2014 to 2019
$28.6M
PICS: A New Horizon for Surgical Critical CareP50GM111152 · NIGMS · UNIVERSITY OF FLORIDA · PI MOORE, FREDERICK A · 2014 to 2018
$10.7M
Giant MagnetoResistive (GMR) Sensors for Measuring Influenza VaccineR01AI125197 · NIAID · STANFORD UNIVERSITY · PI UTZ, PAUL JOSEPH, WANG, SHAN X. · 2016 to 2021
$5.0M
Plasma Protein Biomarker-Based Diagnostics Of Outcome In Sepsis and CAPU01AI066569 · NIAID · NATIONAL CENTER FOR GENOME RESOURCES · PI KINGSMORE, STEPHEN FRANCIS · 2005 to 2010
$2.9M
Bridging Sustainable Distribution of TRBD Bioinformatics ResourcesR24GM102656 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI XIAO, WENZHONG · 2012 to 2014
$1.6M
European Research Council 281824NCATS NIH HHS UL1 TR001417NCRR NIH HHS P20 RR016480NIAID NIH HHS R01 AI125197NIAID NIH HHS U01 AI066569NIAID NIH HHS U19 AI057229NIAID NIH HHS U19 AI109662NIGMS NIH HHS P50 GM111152NIGMS NIH HHS R24 GM102656Wellcome Trust
6 · The paper itself

Abstract

Improved risk stratification and prognosis prediction in sepsis is a critical unmet need. Clinical severity scores and available assays such as blood lactate reflect global illness severity with suboptimal performance, and do not specifically reveal the underlying dysregulation of sepsis. Here, we present prognostic models for 30-day mortality generated independently by three scientific groups by using 12 discovery cohorts containing transcriptomic data collected from primarily community-onset sepsis patients. Predictive performance is validated in five cohorts of community-onset sepsis patients in which the models show summary AUROCs ranging from 0.765-0.89. Similar performance is observed in four cohorts of hospital-acquired sepsis. Combining the new gene-expression-based prognostic models with prior clinical severity scores leads to significant improvement in prediction of 30-day mortality as measured via AUROC and net reclassification improvement index These models provide an opportunity to develop molecular bedside tests that may improve risk stratification and mortality prediction in patients with sepsis.

Indexed as

BiomarkersCommunity-Acquired InfectionsCross InfectionGene Expression ProfilingHumansModels, TheoreticalPrognosisSepsisSeverity of Illness IndexBiomarkers

Identifiers

PMID29449546
PMCPMC5814463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.